P060 Childhood uveitis: epidemiological, clinical and etiological profile, about 52 cases

Rheumatology ◽  
2021 ◽  
Vol 60 (Supplement_5) ◽  
Author(s):  
A Sakhi ◽  
R Chahir ◽  
A Elkettani ◽  
K Bouayed

Abstract Background Childhood uveitis is a rare, often serious condition, and accounts for 2% to13% of all uveitis. It is characterized by an asymptomatic onset delaying the diagnosis and exposing a high risk of complications. The etiological profile of childhood uveitis seems to be different from that of adults. The objective of our work is to analyze the epidemiological, clinical, etiological, therapeutic and disease course characteristics of pediatric uveitis. Method This retrospective study, carried out in a tertiary care center, involved a number of 87 eyes in 52 children under the age of 16, collected over a period extending between January 2015 and September 2019 with a minimum follow-up of 6 months. Results The patients mean age was 8.15 years with a sex ratio of 1.47 and a mean consultation delay of 6.7 months. Uveitis was bilateral in 67.3% of cases. Pan-uveitis predominated, followed by intermediate, anterior and posterior uveitis in 50%, 21%, 17% and 12% of cases, respectively. Uveitis was idiopathic in 67.3% of cases. Inflammatory uveitis was the most frequent aetiology with 5 cases of Behçet's disease, 2 cases of juvenile idiopathic arthritis (JIA) and 2 cases of TINU syndrome. Ophthalmologic complications were dominated by iridocrystalline synechiae in 13.5%, retinal detachment in 10.4%, cataract in 5.4% and macular oedema in 2.7%. Corticosteroid therapy was administered to all children, combined with immunosuppressive therapy in 48% of cases (azathioprine, methotrexate). The use of anti-TNF alpha was justified in 11 patients. The disease course was marked by complete remission in 11 children and partial remission in 15 patients, 26 children presented relapses of their uveitis with satisfactory final visual acuity in 73% of cases. Conclusion Our results show the predominance of panuveitis, probably due to diagnostic delay. Idiopathic uveitis, as described in the literature, and inflammatory causes of Behçet's disease are at the top of the list of etiologies. Pediatric uveitis is a particular entity, which requires regular monitoring by a team of experts in order to avoid eye complications and amblyopia in the youngest.

2005 ◽  
Vol 34 (13) ◽  
pp. 916-918 ◽  
Author(s):  
Nicolas Lanthier ◽  
Christine Parc ◽  
Rodolphe Scavennec ◽  
Robin Dhôte ◽  
Antoine P. Brézin ◽  
...  

2010 ◽  
Vol 30 (5) ◽  
pp. 577-581 ◽  
Author(s):  
Alfredo Adán ◽  
Victoria Hernandez ◽  
Santiago Ortiz ◽  
Juan Jose Molina ◽  
Laura Pelegrin ◽  
...  

Retina ◽  
2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Mohammad Refaat ◽  
Abdussalam M Abdullatif ◽  
Mostafa M Hamza ◽  
Tamer A Macky ◽  
Mohamed-Sameh H El-Agha ◽  
...  

2019 ◽  
Vol 4 (8) ◽  
pp. 502-506
Author(s):  
Prof. Dr. Radha Annamalai ◽  
◽  
Dr. Ansu Ann John ◽  
Prof. M. Muthayya ◽  
◽  
...  

2010 ◽  
Vol 38 (2) ◽  
pp. 387-390 ◽  
Author(s):  
BRICE KRUPA ◽  
ROLANDO CIMAZ ◽  
SEZA OZEN ◽  
MICHEL FISCHBACH ◽  
PIERRE COCHAT ◽  
...  

Objective.To describe the characteristics of a group of pediatric patients with Behçet’s disease (BD) who presented at least 1 episode of thrombosis during their disease course.Methods.We made a retrospective chart review of the clinical, biological, and radiological data of children with BD who presented at least 1 episode of either arterial or venous thrombosis. Data were extracted from both an international pediatric Behçet cohort and files referred from 7 French centers.Results.Twenty-one patients were included. Diagnosis of BD was based on the criteria of the International Study Group for BD. Main locations for thrombosis were the cerebral sinuses, in 11 patients (52.4%); and lower limbs, in 9 patients (40.9%). Recurrent episodes were observed in 4 patients (21%). Thrombophilia measurements were normal in 14 patients out of 21, while anticardiolipin antibodies were positive in 4 patients, and 2 out of 21 had protein C deficiency. One patient had lupus anticoagulant. All patients were treated with colchicine. Corticosteroids were also added for variable periods in 13 patients. Five patients out of 21 were treated with anticoagulants (heparin, then anti-vitamin K) and 3 with antiplatelets (acetylsalicylic acid).Conclusion.Thromboses are a serious complication of BD and may occur early in the disease course. The presence of thrombophilic markers could increase the risk of thrombosis in BD, but the size of our population does not allow any conclusion. An international cohort (PED-BD) is currently in place and will allow study of such cases longitudinally, as well as assessment of the elements that correlate with an increased risk of thrombosis in children with BD.


2020 ◽  
Vol 38 ◽  
pp. 101512 ◽  
Author(s):  
Ertugrul Cagri Bolek ◽  
Alper Sari ◽  
Levent Kilic ◽  
Umut Kalyoncu ◽  
Asli Kurne ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document